Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement with Australian Distributor TCann Pty Ltd.
Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the
“Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that
its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has
successfully entered into a Medical Cannabis Supply and Purchase
Agreement (the “Agreement”) with TCann Pty Ltd., Australia
(“TCann”), an import/export and distribution company of
para-pharmaceutical, medicinal and narcotic products located in
Thornleigh, New South Wales.
Pursuant to the Agreement, NMC will supply
medical grade dried cannabis flower to TCann and TCann will
distribute NMC medical grade dried cannabis products in Australia.
TCann is a licensed cultivator and manufacturer of medicinal
cannabis products. TCann focuses on producing high quality
pharmaceutical-grade cannabis products for patients in Australia
from their Good Manufacturing Practice (GMP) certified
“We are excited to announce our first executed
supply agreement for distribution of Eve’s product to Australia.
Entering this agreement enables Eve to fulfill its strategy to
become one of the foremost exporters of European Union (“EU”) GMP
compliant product from Canada to the world’s foreign cannabis
markets,” commented Melinda Rombouts, President and Chief Executive
Officer at Eve & Co.
ABOUT EVE & CO
Eve & Co, through its wholly owned
subsidiary NMC, holds cultivation and processing licenses under the
Cannabis Act (Canada) for the production and sale of various
cannabis products, including dried cannabis, cannabis plants and
extraction of cannabis oil and has received EU GMP certification.
NMC was Canada’s first female-founded licensed producer of
medicinal marijuana and received its cultivation license from
Health Canada in 2016. Eve & Co is led by a team of
agricultural experts and has a licensed 1,000,000 sq. ft.
greenhouse located in Strathroy, Ontario.
The Company’s website can be visited at
The TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
This news release includes statements containing
certain “forward-looking information” within the meaning of
applicable securities law (“forward-looking statements”).
Forward-looking statements are frequently characterized by words
such as “plan”, “continue”, “expect”, “project”, “intend”,
“believe”, “anticipate”, “estimate”, “may”, “will”, “potential”,
“proposed” and other similar words, or statements that certain
events or conditions “may” or “will” occur, and include, but are
not limited to, the production and sale of bath bombs by the
Company, whether sales of bath bombs will occur, if any at all, or
recur and the timing thereof. Although the Company believes the
expectations expressed in such forward-looking statements are based
on reasonable assumptions, such statements are not guaranteeing of
future performance and involve risks and uncertainties that are
difficult to control or predict. Therefore, actual outcomes and
results may differ materially from those expressed in these
forward-looking statements and readers should not place undue
reliance on such statements. Forward-looking statements are subject
to a variety of risks, uncertainties and other factors that
management believes to be relevant and reasonable in the
circumstances could cause actual events, results, level of
activity, performance, prospects, opportunities or achievements to
differ materially from those projected in the forward-looking
statements, including general business and economic conditions,
changes in laws and regulations, product demand, changes in prices
of required commodities, competition, the effects of and responses
to the COVID-19 pandemic and other risks, uncertainties and factors
set out under the heading “Risk Factors” in the Company’s
management’s discussion and analysis dated May 31, 2021 (the
“MD&A”) and filed with Canadian securities regulators available
on the Company’s issuer profile on SEDAR at www.sedar.com. The
Company cautions that the list of risks, uncertainties and other
factors described in the MD&A is not exhaustive and other
factors could also adversely affect its results. Readers are urged
to consider the risks, uncertainties and assumptions carefully in
evaluating the forward-looking statements and are cautioned not to
place undue reliance on such information. These forward-looking
statements speak only as of the date on which they are made, and
the Company undertakes no obligation to update them publicly to
reflect new information or the occurrence of future events or
circumstances unless otherwise required to do so by law.
For further information, please
Melinda RomboutsPresident and Chief Executive OfficerEve & Co
IncorporatedTelephone: (855) 628-6337
Eve & (TSXV:EVE)
Historical Stock Chart
From Apr 2022 to May 2022
Eve & (TSXV:EVE)
Historical Stock Chart
From May 2021 to May 2022